Peter J. Arduini
2018 - Integra LifeSciences Holdings
Compensation breakdown
| Non-Equity Incentive Plan | $1,232,640 |
|---|---|
| Option Awards | $1,635,003 |
| Salary | $947,916 |
| Stock Awards | $3,815,037 |
| Other | $17,216 |
| Total | $7,647,812 |
Arduini received $3.8M in stock awards, accounting for 50% of the total pay in 2018.
Arduini also received $1.2M in non-equity incentive plan, $1.6M in option awards, $947.9K in salary and $17.2K in other compensation.
Rankings
In 2018, Peter J. Arduini's compensation ranked 1,084th out of 14,244 executives tracked by ExecPay. In other words, Arduini earned more than 92.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,084 out of 14,244 | 92nd |
Division Manufacturing | 363 out of 5,765 | 94th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 47 out of 849 | 95th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 22 out of 547 | 96th |
Industry Surgical and Medical Instruments and Apparatus | 14 out of 348 | 96th |
Pay ratio
| Peter J. Arduini's Pay | $7,647,812 |
|---|---|
| Median Employee's Pay | $73,170 |
| Pay Ratio | 105to 1 |
In 2018, the annual total compensation of Peter J. Arduini was $7,647,812.
The annual total compensation of the median employee at Integra LifeSciences Holdings was $73,170.
The ratio of Peter J. Arduini's pay to the pay of median employee was therefore 105 to one.
Arduini's colleagues
We found five more compensation records of executives who worked with Peter J. Arduini at Integra LifeSciences Holdings in 2018.
2018
Richard Gorelick
Integra LifeSciences Holdings
General Counsel
2018
Glenn Coleman
Integra LifeSciences Holdings
Chief Financial Officer
2018
Daniel Reuvers
Integra LifeSciences Holdings
Corporate Vice President, President, Codman Surgical Solutions
2018
Robert Davis
Integra LifeSciences Holdings
Corporate Vice President, President, Orthopedics and Tissue Technologies
2018
Eric Schwartz
Integra LifeSciences Holdings
General Counsel
News
April 8, 2022
April 9, 2021
April 8, 2020
April 16, 2019